Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Protagonist Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Protagonist Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Protagonist Therapeutics (United States)?

ScholarIQrecord summary

Protagonist Therapeutics (United States) is a research organisation in Newark, United States. OpenAlex records 216 works and 2,994 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Protagonist Therapeutics (United States) have?

ScholarIQindexed works

Protagonist Therapeutics (United States) has 216 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Protagonist Therapeutics (United States) have?

ScholarIQcitation count

Protagonist Therapeutics (United States) has 2,994 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Protagonist Therapeutics (United States)?

ScholarIQresearcher count

Protagonist Therapeutics (United States) has 1 researchers in the ScholarIQ index.

What is the average h-index at Protagonist Therapeutics (United States)?

ScholarIQavg h-index

Protagonist Therapeutics (United States) has an average h-index of 56 in OpenAlex.

What is the ROR of Protagonist Therapeutics (United States)?

ScholarIQror

The ROR for Protagonist Therapeutics (United States) is on the source record.

What is the OpenAlex record for Protagonist Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Protagonist Therapeutics (United States) is on the source record.

Who are the most-cited researchers behind Protagonist Therapeutics (United States)?

ScholarIQtop researchers by citations
1
Arturo Molina · Prostate Cancer Treatment and Research
214 works21,532 citations

What are the most-cited papers on Protagonist Therapeutics (United States)?

ScholarIQmost cited works
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N., Robert J. Jones, Oscar B. Goodman, Fred Saad, John Staffurth, Paul N. Mainwaring, Stephen Harland, Thomas W. Flaig, Thomas E. Hutson, Tina Cheng, Helen Patterson, John D. Hainsworth, Charles J. Ryan, Cora N. Sternberg, Susan Ellard, Aude Fléchon, Mansoor N. Saleh, Mark C. Scholz, Eleni Efstathiou, Andrea Zivi, Diletta Bianchini, Yohann Loriot, Nicole Chieffo, Thian Kheoh, Christopher M. Haqq, Howard I. Scher
New England Journal of Medicine. 20114,422 CitationsOPEN ACCESS
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, Arturo Molina, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Paul N. Mainwaring, Josep M. Piulats, Siobhan Ng, Joan Carles, Peter F.A. Mulders, Ethan Basch, Eric J. Small, Fred Saad, Dirk Schrijvers, Hendrik Van Poppel, Som D. Mukherjee, H. Suttmann, Winald R. Gerritsen, Thomas W. Flaig, Daniel J. George, Evan Y. Yu, Eleni Efstathiou, Allan J. Pantuck, Eric Winquist, Celestia S. Higano, Mary-Ellen Taplin, Youn Park, Thian Kheoh, Thomas W. Griffin, Howard I. Scher, Dana E. Rathkopf
New England Journal of Medicine. 20122,811 CitationsOPEN ACCESS
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
Howard I. Scher, Glenn Heller, Arturo Molina, Gerhardt Attard, Daniel C. Danila, Xiaoyu Jia, Weimin Peng, Shahneen Sandhu, David Olmos, Ruth Riisnaes, Robert G. McCormack, Tomasz Burzykowski, Thian Kheoh, Martin Fleisher, Marc Buyse, Johann S. de Bono
Journal of Clinical Oncology. 2015382 CitationsOPEN ACCESS

How much of the research on Protagonist Therapeutics (United States) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
33%
Bronze
67%
Closed
0%
470M+ articles · free account